Shopping Cart
- Remove All
- Your shopping cart is currently empty
D-3263 is an agonist of transient receptor potential melatonin member 8 (TRPM8) with potential antitumor activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,670 | 1-2 weeks | |
50 mg | $2,180 | 1-2 weeks | |
100 mg | $2,800 | 1-2 weeks |
Description | D-3263 is an agonist of transient receptor potential melatonin member 8 (TRPM8) with potential antitumor activity. |
In vitro | D-3263 triggers calcium flux and induces cell death in TRPM8-expressing cells in vitro. |
In vivo | D-3263 alone (50 or 100 mg / kg / d) or in combination with finasteride (10 mg / kg / d) can lead to decreased prostate hyperplasia in rats, with evidence of dose response. The highest dose of TRPM8 agonist D-3263 combined with finasteride caused lower prostate weight than the highest dose of D-3263 or finasteride alone, indicating a potential additive effect. |
Molecular Weight | 373.49 |
Formula | C21H31N3O3 |
Cas No. | 947257-66-1 |
Relative Density. | 1.137 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.